Beta human chorionic gonadotropin (HCG): Female, premenopausal nonpregnant: ˂1.0 U/L; female, postmenopausal: ˂7.0 U/L; male: ˂1.4 U/L CA19.9: 0–37 U/mL Carcinoembryonic antigen (CEA): ˂2.5 ng/mL Prostatic acid phosphatase (PAP): 0-3 U/dL Prostate-specific antigen (...
Yang X, Figueroa J, Hewitt S, Falk R, Pfeiffer R, Lissowska J, et al. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer. Breast Cancer Res Treat 2013:137:837-47....
Lee, MD, PhD JAMA Oncology Podcast (14:50) Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal BMI 1x 0:00 / 0:00 Subscribe to Podcast Key Points Question Are increased levels of body fat in women with normal body mass index associated with an elevated...
Induction of milk protein synthesis both in vivo and in vitro is dependent on PRL (1). Less well recognized is the mitogenic action of PRL. Although the ovarian steroids, estrogen and progesterone, are involved in mammary ductal growth and branching, strong evidence...年份: 1999 ...
FULL PAPER British Journal of Cancer (2013) 108, 1408–1414 | doi: 10.1038/bjc.2013.114 Keywords: breast cancer; obesity; tamoxifen; aromatase inhibitor; BMI Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: ...
Cumming DC, Honore LH, Scott JZ, Williams KP: The late luteal phase in infertile women: Comparison of simultaneous endometrial biopsy and progesterone levels. Fertil Steril 1985;43:715–719. Wentz AC: Endometrial biopsy in the evaluation of infertility. Fertil Steril 1980;33:121–124. Witten BI...
Menopause is a period in which the production of female hormones (estrogens and progesterone) gradually decreases, leading to the cessation of menstrual cycles and the loss of reproductive capability. This period begins around the age of 40 and lasts until the age of 60–65. Menopause usually ...
Progesterone is also mitogenic in the premenopausal and postmenopausal human breast [3]. The greater risk of breast cancer in postmenopausal women receiving combined estrogen plus progestin hormone replacement therapy than in those receiving estrogen alone indicates a significant role for proges-terone in...
Briefly, the majority of women were white, postmenopausal, and had dense breasts. The mean patient age was 53 years (range 32 to 76). Quantification of MMP2, MMP9, MMP14, and collagen IV expression in LCIS MMP2, MMP9, MMP14, and collagen IV expression was evaluated using dual ...
Receptors, ProgesteroneMenopauseImmunohistochemistryFemaleTamoxifenImmunohistochemical assays have been employed to study the expression of ER, PgR, EGFR and Ki67 immunostaining in normal breast tissue (n = 76). The expression of ER and PgR was highly variable in both pre and postmenopausal women and ...